Literature DB >> 28435792

Retroperitoneoscopic Partial Nephrectomy for a Horseshoe Kidney Tumor.

David Nikoleishvili1, Givi Koberidze1.   

Abstract

Horseshoe kidney is the most common renal fusion anomaly found in about 0.15% to 0.25% of the population. Renal cell carcinoma associated with a horseshoe kidney has been described in fewer than 200 cases. Its incidence and prognosis seems to be not different from those of the general population, but surgical management may be challenging due to unique anatomic features of horseshoe kidneys, such as highly variable vasculature. We report a case of a 69-year-old male with an incidental 48-mm solid mass in the left moiety of a horseshoe kidney, successfully treated by retroperitoneoscopic partial nephrectomy.

Entities:  

Keywords:  Horseshoe kidney; Laparoscopic partial nephrectomy; Renal cell carcinoma

Year:  2017        PMID: 28435792      PMCID: PMC5394214          DOI: 10.1016/j.eucr.2017.03.013

Source DB:  PubMed          Journal:  Urol Case Rep        ISSN: 2214-4420


Introduction

Horseshoe kidneys are the most common renal fusion anomaly found in about 0.15% to 0.25% of the population, with a 2:1 ratio in men.1, 2 Malignancies in the horseshoe kidney are rare, occurring in 5% to 13% of patients with these anomalies. Renal cell carcinoma (RCC) accounts for about 50% of tumors found in the horseshoe kidney. However, its incidence as well as prognosis appears to be not different from those of the general population. To our knowledge, only four cases of laparoscopic nephron-sparing surgery for tumors in the horseshoe kidney have been published; two of them performed transperitoneally and the other two via a retroperitoneal approach. In this report, we describe the case of retroperitoneal laparoscopic partial nephrectomy for a solid renal mass in the left moiety of a horseshoe kidney.2, 3, 4, 5

Case presentation

A solid tumor in the left moiety of a horseshoe kidney was incidentally found in a 69-year old man on a routine abdominal ultrasound. Contrast-enhanced computed tomography (CT) with three-dimensional (3D) reconstruction identified a 48-mm enhancing lower-pole, posteriorly located mass in the left moiety of the horseshoe kidney (Figure 1, Figure 2). The tumor was limited to the kidney, without any evidence of metastasis or lymph node lesions. There was no vascular or collecting system involvement. P.A.D.U.A. nephrometry score was 7p.
Figure 1

Axial contrast-enhanced abdominopelvic CT showing a 48-mm lower-pole mass in the left moiety of the horseshoe kidney.

Figure 2

CT scan with three-dimensional reconstruction.

Axial contrast-enhanced abdominopelvic CT showing a 48-mm lower-pole mass in the left moiety of the horseshoe kidney. CT scan with three-dimensional reconstruction. The patient was not a smoker. The medical history was notable for long-standing, well-controlled diabetes type 2 and hypertension. Preoperative serum creatinine was 84.3 μmol/L and estimated glomerular filtration rate (eGFR) was 81 mL/min. The preoperative American Society of Anesthesiologists (ASA) score was 2. A retroperitoneal laparoscopic partial nephrectomy was used to remove the tumor. Under general anesthesia, the patient was placed in a flank position and modified port placement template was used to establish a retroperitoneal access, with the camera port placed on the middle axillary line, an 11-mm trocar inserted in the anterior axillary line, and two 5-mm working ports distributed, respectively, on the anterior side and the posterior axillary line. Following opening of the Gerota's fascia, the main left renal artery – supplying mainly upper pole and left side of the isthmus area – was identified, clamped using a tourniquet, and the protruding renal mass was completely resected with monopolar scissors. The resected renal parenchyma was sutured in two layers, supported with surgical bolsters and absorbable hemostats. The specimen was extracted in an Endo-bag and a drain was left in place. The operative time was 156 minutes, with warm ischemia time of 24 minutes. The estimated blood loss was 75 mL. The drain was removed on postoperative day 2 and the patient was discharged uneventfully on day 4. The pathologic examination of the specimen confirmed clear-cell RCC pT1b Fuhrman II, with negative surgical margins. At 6 months, follow-up CT was negative for local recurrence and metastasis. There was no evidence of collecting system obstruction and kidney function tests were normal.

Discussion

Tumors arising from kidneys with fusion anomalies are reported in 5% to 13% of the patients. Renal cell carcinoma is the most commonly reported tumor of the horseshoe kidney, identified in about 50% of cases.1, 2 While kidneys with fusion anomalies appear to have a higher risk of developing nephroblastomas and urothelial carcinoma, the incidence of RCC is no higher than that of the general population and prognosis depends on the same factors as in nonfused kidneys. However, the unique anatomic features of horseshoe kidneys, such as highly variable vasculature, abnormal kidney position, the presence of the isthmus, and possible associated anomalies, can make surgery for a horseshoe kidney tumor technically challenging. Therefore, detailed preoperative radiological evaluation of these anatomical factors and proper surgical planning are essential.1, 2, 3, 5 Open radical heminephrectomy or partial nephrectomy has been used for most tumors involving kidneys with fusion anomalies. Recent series suggest they can be treated with partial nephrectomy, when feasible, with limited blood loss and preservation of renal function, but overall and major complication rates are reportedly relatively high. With advances in minimally invasive surgery, the open surgical technique has been duplicated laparoscopically. To our knowledge, only four cases of laparoscopic partial nephrectomy for horseshoe kidney tumors have been published in the literature, first by Molina and Gill in 2003. Two of them reported the surgery performed transperitoneally and the other two via a retroperitoneal approach2, 3, 4, 5 (Table 1).
Table 1

Summary of literature.

AuthorYearAge, yearSexSideSize, cmSurgeryOperating Time, minEstimated Blood Loss, mLWIT, minPathologyComplications
Molina and Gill200368MR2R-LPN19810031Hemorrhagic cystNo
Tsivian et al200762FR2T-LPN21070NROncocytomaNo
Lee at al201121FL4R-LPN18649028Metanephric adenomaNo
Benidir et al201458MR4T-LPN18020025RCCNo
Present case201769ML4.8R-LPN1567524RCCNo

NR: Not reported; RCC: renal cell carcinoma; R-LPN: Retroperitoneal laparoscopic partial nephrectomy; T-LPN: Transperitoneal laparoscopic partial nephrectomy; WIT: Warm ischemia time.

Summary of literature. NR: Not reported; RCC: renal cell carcinoma; R-LPN: Retroperitoneal laparoscopic partial nephrectomy; T-LPN: Transperitoneal laparoscopic partial nephrectomy; WIT: Warm ischemia time.

Conclusion

The unique anatomic features of horseshoe kidneys, such as highly variable vasculature, abnormal kidney position, the isthmus, and possible associated anomalies, can make surgery for a horseshoe kidney tumor technically challenging. Therefore, detailed preoperative radiological evaluation of these anatomical factors and careful surgical planning are essential. Though technically difficult, laparoscopic nephron-sparing surgery seems feasible and can be considered in these scenarios.

Consent

Written informed consent for the publication of this case report and the accompanying images was obtained from the patient. A copy of the written consent in the patient's native language is available for review.

Conflicts of interest

None declared.
  5 in total

1.  Laparoscopic partial nephrectomy in a horseshoe kidney.

Authors:  Wilson R Molina; Inderbir S Gill
Journal:  J Endourol       Date:  2003-12       Impact factor: 2.942

2.  Laparoscopic partial nephrectomy for tumour excision in a horseshoe kidney.

Authors:  Alexander Tsivian; Avraham Shtricker; Shalva Benjamin; A Ami Sidi
Journal:  Eur Urol       Date:  2006-11-03       Impact factor: 20.096

3.  Surgical Treatment of Tumors Involving Kidneys With Fusion Anomalies: A Contemporary Series.

Authors:  Roy Mano; A Ari Hakimi; Alexander I Sankin; Itay A Sternberg; Michael S Chevinsky; Paul Russo
Journal:  Urology       Date:  2016-08-03       Impact factor: 2.649

4.  Laparoscopic partial nephrectomy for renal cell carcinoma in a horseshoe kidney.

Authors:  Tarik Benidir; Tiago Jacometo Coelho de Castilho; Guilherme Rodrigo Lobo Cherubini; Murilo de Almeida Luz
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

5.  Retroperitoneoscopic partial nephrectomy in a horseshoe kidney.

Authors:  Yong Seung Lee; Ho Song Yu; Myung Up Kim; Ho Sung Jang; Dae Hun Lee; Chan Dong Yeom; Jong Ho Hwang; Won Sik Ham
Journal:  Korean J Urol       Date:  2011-11-17
  5 in total
  5 in total

1.  Robotic-assisted laparoscopic partial nephrectomy for renal cell carcinoma in horseshoe kidney: a hybrid technique with conventional laparoscopic surgery.

Authors:  Kazuyuki Numakura; Yumina Muto; Ryohei Yamamoto; Atsushi Koizumi; Taketoshi Nara; Sohei Kanda; Mitsuru Saito; Shintaro Narita; Takamitsu Inoue; Tomonori Habuchi
Journal:  Int Cancer Conf J       Date:  2020-06-04

2.  Robot-assisted laparoscopic partial nephrectomy for horseshoe kidney: A case report.

Authors:  Atsuko Fujihara; Fumiya Hongo; Tsukasa Narukawa; Takeshi Nomura; Yasuhiro Yamada; Osamu Ukimura
Journal:  IJU Case Rep       Date:  2019-07-23

3.  Retroperitoneoscopic nephrectomy for a horseshoe kidney with hydronephrosis and inflammation: A case report.

Authors:  Qing-Tao Yang; Yu-Xiang Hong; Gao-Ming Hou; Jun-Hong Zheng; Xu-Xia Sui
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Laparoscopic nephron-sparing surgery for a tumor near the isthmus of a horseshoe kidney with a complicated blood supply.

Authors:  Zhiqiang Shao; Shanfeng Tan; Xiaohong Yu; Hongjun Liu; Yongjun Jiang; Jiangping Gao
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

5.  Robot-assisted partial nephrectomy via retroperitoneal approach in a patient with horseshoe kidney.

Authors:  Shoko Uketa; Yousuke Shimizu; Ritsuki Yamaguchi; Noriaki Utsunomiya; Sojun Kanamaru
Journal:  IJU Case Rep       Date:  2021-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.